X Bioscience PCL (BKK:XBIO) YoY EBITDA Growth : -38.64% (As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is X Bioscience PCL YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. X Bioscience PCL's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -38.64%.

X Bioscience PCL's EBITDA per Share for the three months ended in Dec. 2024 was ฿-0.06.

X Bioscience PCL YoY EBITDA Growth Historical Data

The historical data trend for X Bioscience PCL's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL YoY EBITDA Growth Chart

X Bioscience PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-121.22

118.64

-563.64

56.21

-94.03

X Bioscience PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															78.74	-320.00	-157.14	-320.00	-38.64

X Bioscience PCL YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

X Bioscience PCL's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.13	-	-0.067)	/	\| -0.067 \|
=	-94.03 %

X Bioscience PCL's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-0.061	-	-0.044)	/	\| -0.044 \|
=	-38.64 %

X Bioscience PCL YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

X Bioscience PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

XBIO-W7:Thailand

Address

Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400

Website

https://www.xbio.co.th

X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.